Key result
Wild-type ATTR amyloidosis presenting with liver dysfunction can mask concurrent rare liver diseases.
Case Report (n=2)
Clinicians must maintain a broad differential diagnosis for liver disease in patients with ATTRwt cardiac amyloidosis, as they may have concurrent, unrelated rare conditions rather than simple congestive hepatopathy.
Answers are grounded in this paper and cite their sources.
May warrant broader differential for liver abnormalities in ATTRwt cardiac amyloidosis; leaves open frequency of concurrent rare liver diseases.
Wild-type ATTR cardiac amyloidosis (ATTRwt-CA) is not as rare as previously thought to be. Patients with infiltrative cardiac amyloidosis often present with right-sided heart failure (HF) symptomatology. Clinically significant liver disease and cirrhosis has not been reported in ATTRwt-CA. We present two cases of ATTRwt-CA with right-sided HF and abnormal liver function tests initially thought to be secondary to congestive hepatopathy but found to have rare and unrelated liver disease. These cases highlight the importance of developing a broad differential diagnosis and leveraging a multidisciplinary team approach in evaluating patients for unusual causes of cirrhosis/other chronic liver diseases when ATTR cardiac amyloidosis patients present with congestive hepatopathy.
No takes yet. Share an insight, caveat, or question.
Bhattacharya et al. (2021) conducted a case report in Wild-type ATTR cardiac amyloidosis (ATTRwt-CA) with concurrent liver disease (n=2). Wild-type ATTR cardiac amyloidosis with concurrent rare liver disease was evaluated. Two cases of wild-type ATTR cardiac amyloidosis presenting with right heart failure and abnormal liver function tests were found to have concurrent, unrelated rare liver diseases (alpha-1 antitrypsin deficiency and hemochromatosis).
Synapse has enriched 10 related papers. Consider them for comparative context: